of gastritis (80%) and gastroduodenal ulcer disease (15%-20%) and the only bacterial pathogen believed to cause cancer (IARC Working Group 1994). 3, 4 Prevalence of infection with H pylori varies from less than 10% in asymptomatic children in Western countries to approximately 90% in some developing countries. Most infections occur during childhood, whereas the H pylori status of adults remains stable. 5, 6 Furthermore, although there are wide interindividual variations in the level of gastritis as well as in the inflammatory response to H pylori, the intraindividual gastritis pattern is constant over time. 7 Approximately 5% to 10% of a population is never infected with H pylori, even in the presence of high exposure rates. 8 A contribution of genetic factors to H pylori susceptibility is supported by differences in H pylori susceptibility between African Americans and US residents of European ancestry after adjusting for socioeconomic status, age, and living conditions. 9 Significantly higher concordance for H pylori infection in monozygotic compared with dizygotic twins, or for household members who are siblings rather than unrelated persons, 10 also argues for a genetic influence, with a heritability estimate in twins of 57%. 10 The key pathophysiological event in H pylori infection is the initiation of an inflammatory response. This response is triggered by bacterial membrane components, namely, lipopolysaccharides and lipid A, as well as cytotoxins and H pylori urease activity. 11 So far, few candidate gene studies have analyzed human host genetic factors for susceptibility to H pylori infection and persistence. [12] [13] [14] Several studies have demonstrated that genetic variations, eg, in IL1B, modulate the susceptibility for gastric cancer among H pyloriinfected individuals. 15, 16 This genome-wide association study (GWAS) for determinants of H pylori seroprevalence was conducted in 2 large population-based cohorts, the Study of Health in Pomerania (SHIP) and the Rotterdam Study (RS-I and RS-II). Subsequent whole-blood transcriptome analyses were conducted in the independent SHIP-TREND and RS-III populations.
METHODS

Study Cohorts
The SHIP study consists of 2 independent prospectively collected populationbased cohorts in Northeastern Germany, SHIP and SHIP-TREND. The study design of SHIP has been previously described in detail. 17 The first patient for the SHIP study was recruited in October 1997 and the last in May 2001. SHIP-TREND is an additional independent cohort from the same region, with individuals newly recruited between September 2008 and summer 2012; for details of SHIP-TREND, see the eAppendix available at http: //www.jama.com.
The SHIP study has 2 main objectives: to assess prevalence and incidence of common risk factors, subclinical disorders, and clinical diseases; and to investigate the complex associations among risk factors, subclinical disorders, and clinical diseases. A particular characteristic of SHIP is that it does not specifically address a single selected disease; rather, it attempts to describe health-related conditions with the widest focus possible.
The Rotterdam Study is a large, population-based prospective study of elderly individuals of European ancestry consisting of 3 cohorts (RS-I, RS-II, RS-III) of individuals residing in a suburb of Rotterdam, the Netherlands, and has been described in detail. [18] [19] [20] The study targets cardiovascular, endocrine, hepatic, neurologic, ophthalmic, psychiatric, and respiratory diseases. Baseline recruitment and measurements for the RS-I study were obtained between 1990 and 1993. Data from SHIP, RS-I, and RS-II were used for the GWAS; data from SHIP-TREND and RS-III were used for the transcriptome analysis.
Written informed consent was obtained from all participants, and the medical ethics committee of the Erasmus Medical Center Rotterdam and University Medicine Greifswald approved the study.
Phenotype Determination: Seroprevalence and Bacterial Load
Anti-H pylori serum IgG antibody titers were measured using commercial enzyme immunoassays (Pyloriset EIA-G III ELISA; Orion). Seroprevalence, an indicator for current or previous infection, was defined as an anti-H pylori IgG titer equal to or greater than 20 U/mL, according to the manufacturer's recommendation. 21 In comparison with culture or CLO (Campylobacter-like organism) testing (rapid urease activity testing), using this cutoff value should detect H pylori infection with a sensitivity of 97.8%, a specificity of 58.0%, and an accuracy of 78.7%. The positive predictive value for the Pyloriset EIA-G III ELISA immunoassay is reported as 71.5% and the negative predictive value as 96.2%. 22 Individuals with the lowest 75% of the IgG titer distribution comprised the control group. Infection was defined in accordance with international convention when H pylori was detected by fecal H pylori antigen testing. 23 A significant correlation between titer levels and actual infection has been reported. 22 To investigate the association of gene expression levels and the fecal H pylori antigen titer, individuals with high bacterial load (based on fecal H pylori antigen titer, optical density [OD]Ͼ1; see below) were studied to determine if they also exhibited the highest 25% of gene expression levels of the respective 4p14-region genes.
The H pylori antigen ELISA kit (Immunodiagnostics) was used to detect H pylori antigen in stool. One hundred mg of feces was stored at Ϫ20ЊC before analysis. According to the manufacturer's instructions, all participants with an OD greater than or equal to 0.025 at 450 nm are positive for H pylori infection. Sensitivity for this test is reported as 97.7% and specificity as 96.3%. For the quantitative correlation between fecal H pylori antigen and bacterial load, a Pearson correlation coefficient of 0.222 is reported in the literature.
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Genotyping and Imputation
Genotyping of the SHIP probands using the Affymetrix SNP 6.0 array was performed as described previously. 24 Genotyping of the SHIP-TREND participants was performed using the Illumina HumanOmni2. 
Whole-Blood Transcriptome Analysis
For SHIP-TREND and RS-III, whole blood was collected in PAXgene tubes (BD). Total RNA in SHIP-TREND was prepared using a QIA cube device in combination with the Blood miRNA Kit (Qiagen), according to manufacturer's protocols. Subsequent RNA sample processing and hybridization with Illumina HumanHT-12 v3 Expression BeadChips was performed as described by the manufacturer (Illumina) at the Helmholtz Zentrum Mü nchen. The SHIP-TREND expression data set is available at the GEO (Gene Expression Omnibus) public repository under accession number GSE36382. For details, see the eAppendix.
In RS-III, RNA was amplified and labeled (Ambion TotalPrep RNA) and hybridized with the Illumina HumanHT-12 v4 Expression BeadChips as described by the manufacturer's protocol. The RS-III expression data set is available at the GEO public repository under accession number GSE33828. For details see the eAppendix.
Statistical Analyses
The case and control groups were defined according to their anti-H pylori IgG-titer as described above. Detailed information on the study cohort characteristics are provided in TABLE 1. Genome-wide association analysis for SHIP was performed with Quicktest (http://toby.freeshell.org/software /quicktest.shtml) using a logistic regression model with adjustment for sex and age. For RS-I and RS-II, sex-and age-adjusted GWASs were performed using MACH2DAT (http://www.sph .umich.edu/csg/abecasis/MaCH/) implemented in GRIMP. 25 Only SNPs with a minor allele frequency (MAF) greater than 1% as well as those available in all 3 cohorts were considered for further analyses.
Meta-analyses were conducted by an inverse-variance weighted fixed-effects model using METAL (www.sph.umich.edu/csg/abecasis /metal). 26 The random-effects model was calculated in R using the package metafor. 27 Genomic control was applied to the individual studies' GWAS results ( RS-I =1.008, RS-II =1.012, SHIP =1.000). Because the genomic inflation factor of the combined meta-analysis was below 1 (=0.999), no genomic control was applied for those results.
To assess whether there were multiple independently associated SNPs within the loci found in the combined meta-analysis, a clumping analysis was performed using PLINK 28 (1-megabase distance, r 2 Ͼ0.01, HapMap R28 CEU genotype data set), but no additional hits were found. P =5ϫ10 Ϫ8 was used as the threshold for genome-wide significance, and 2-sided significance testing was performed.
Expression analyses in SHIP-TREND were performed using quantilenormalized and log 2 -transformed gene expression data. Expression quantitative trait loci (eQTL) analyses in SHIP-TREND and RS-III used quantilenormalized, log 2 -transformed, probecentered, and standardized gene expression data. To reduce the number of false-positive and false-negative eQTL association results, in a first step a principal component analysis of the matrix of gene expression data was performed. 29 In a second step, the gene expression profiles of the individuals were adjusted for the first 50 principal components, 29 which represent the largest factors related to variation of gene expression levels. For details see eAppendix, eTable 1A and B, and eFigure 1A-F.
RESULTS
Prevalence and Frequency of H pylori Seroprevalence
Some level of seroprevalence throughout the study was detected in 6160 of 10 938 participants (56.3%) (SHIP, RS-I, and RS-II) ( Table 1) . Based on the predefined phenotypic seroprevalence in the top 25% of the study population, a total of 2623 cases (25%) and 7862 controls (75%) were used for GWAS meta-analysis (SHIP, RS-I, and RS-II) ( Table 1) . To increase specificity and reduce the number of false-positive H pylori infections in the case group of the GWAS, the cutoff was set to the upper 25% of the IgG titer distribution of the corresponding cohort (124.5 U/mL for SHIP, 136.8 U/mL for RS-I, and 88.9 U/mL for RS-II).
GWAS Meta-analysis
Two genome-wide significant loci were identified (FIGURE 1) by combining the data from RS-I, RS-II, and SHIP (n = 10 485, for which H pylori serology and genotyping data were available) using a fixed-effects metaanalysis model. The TLR locus on 4p14 exhibited the lowest P value (FIGURE 2A) Figure 2B ). This SNP is located in an intron of FCGR2A encoding the Fc␥ receptor 2a. The I 2 heterogeneity measures for the top-ranked SNPs 30 (57.3% for rs10004195; 22.6% for rs368433) indicated high and low between-study heterogeneity, respectively. To take into account that the effect of the SNP might differ between the studies as implicated by the high heterogeneity, a random-effects metaanalysis was applied to the genomewide significant findings to ensure that the combined effect of the SNP was not the result of a large effect in a single cohort. For rs10004195 the association P value increased to 6.5 ϫ 10 Ϫ9 using this model, and the combined effect estimate was nearly the same (OR, 0.69 [95% CI, 0.61-0.79]), indicating that the observed association was not completely driven by a single study. For SNP rs368433, the association P value and 
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Putative Functional Context of the Genome-wide Significant SNPs
The protein-coding sequences of the genes closest to the top-ranked SNPs were analyzed for nonsynonymous SNPs in linkage disequilibrium with r 2 Ն0.6. Using the 1000 Genomes database in the SNAP SNP Proxy search tool, 31 2 nonsynonymous SNPs were identified in TLR1 and 1 SNP in TLR10 in linkage disequilibrium with the topranked SNP (rs10004195). In TLR1, the previously mentioned rs4833095 (r 2 =1.0) and rs5743618 (r 2 = 0.95) are nonsynonymous SNPs. Whereas rs4833095 causes the amino acid substitution Asn248Ser, rs5743618 results in the Ser602Ile substitution. In TLR10, rs4129009 (r 2 = 0.77) is located close to the 3' end of the single protein-coding exon of the gene and corresponds to the Ile775Val substitution. This TLR10 amino acid position is localized within the intracellular TIR (toll/interleukin-1 receptor) domain that participates in the transduction of extracellular signaling. 32 For the topranked SNP at the 1q23.3 locus (rs368433; Figure 2B ), no nonsynonymous SNPs in linkage disequilibrium were found.
Association of Anti-H pylori IgG Titers and H pylori Stool Antigen in SHIP-TREND
To explore the relationship between the TLR locus and H pylori infection in more detail, additional analyses in SHIP-TREND were carried out. H pylori stool antigen levels and measured anti-H pylori IgG titers were found to have a significant positive correlation (Spearman =0.59, P =2ϫ 10 Ϫ90 ).
Cis-eQTL Analysis of the Significant GWAS Hits in Whole Blood
Integrative analysis of blood expression profiles with genome-wide SNP data in 1763 participants from SHIP-TREND and RS-III were used to investigate the potential causal relationship between gene(s) located at the loci shown to be associated with H pylori susceptibility. Variation at rs10004195, the top-ranked SNP at the TLR locus (4p14), was significantly correlated with the mRNA levels of TLR1 (ID: 6520451; P = 2.1 ϫ 10 Ϫ 4 for SHIP-TREND and P =3.2ϫ10
Ϫ17 for RS-III) (FIGURE 3A, eTable 5, eFigure 2). Variation at the linked nonsynonymous SNP rs4833095 was also significantly associated with TLR1 (ID:6520451) mRNA expression levels. Among the three TLR genes only TLR1 was differentially expressed. TLR1 was differentially expressed per copy number of the minor rs10004195-A allele (␤ = Ϫ0.23 [95% CI, Ϫ0.34 to Ϫ0.11]; P = 2.1 ϫ 10 Ϫ4 ). The eQTL-results for rs10004195 and all available TLR probes are shown in eTable 6.
Variation at rs368433, the topranked SNP of the second genomewide significant locus (1q23.3), was significantly associated with expression levels of FCGR2A, FCGR2B, and HSPA6 represented by 7 probes (Figure 3B , eTable 6, eFigure 3A and B). Significant associations were found for A, Residual (ie, after adjustment for technical effects and potential confounders; overall mean centered) mean log 2 -transformed gene expression levels corresponding to gene-specific mRNA levels in whole blood and 95% CIs (error bars) per genotype group of TLR1 (ID:6520451), adjusted for the first 50 eigenvectors with respect to rs10004195 for Study of Health in Pomerania-TREND (SHIP-TREND) (genotype distribution: TT=614, TA=315, AA=47) and Rotterdam Study III (RS-III) (genotype distribution: TT=439, TA=269, AA=54). B, Residual (ie, after adjustment for technical effects and potential confounders, and overall mean-centered) mean log 2 -transformed gene expression levels corresponding to gene-specific mRNA levels in whole blood and 95% CIs (error bars) per genotype group of FCGR2B (ID:6650341), adjusted for the first 50 eigenvectors with respect to rs368433 for both SHIP-TREND (genotype distribution: TT=765, TC=191, CC=20) and RS-III (genotype distribution: TT=551, TC=198, CC=13). For cis-eQTL (expression quantitative trait loci) analysis, all genes in a Ϯ250-kilobase region of the 2 top-ranked single-nucleotide polymorphisms (SNPs) from the genome-wide association study were chosen. FCGR2B (ID:6650341; P =9.5ϫ 10
Ϫ19
for SHIP-TREND and P=2.5ϫ10 Ϫ20 for RS-III). FCGR2B expression levels increased in participants carrying 1 or more minor alleles in both populations, whereas expression levels of HSPA6 and FCGR2A decreased with each minor allele. No significant association between fecal H pylori antigen and the expression of FCGR2A and 2B was detected in whole blood.
Relationship Between Bacterial
DISCUSSION
This GWAS on H pylori seroprevalence, conducted in 2 populationbased cohorts including a total of 10 938 participants, identified 2 genomewide significant loci located at 4p14 and 1q23.3 associated with H pylori seroprevalence. These findings were further explored in 1763 additional study participants in whom gene expression levels were studied in whole blood and 961 participants in whom bacterial load was measured in stool samples.
The 4p14 region encodes the TLR1, TLR6, and TLR10 genes; TLR1 was identified as the receptor most likely causatively associated with H pylori seroprevalence. This conclusion is biologically plausible because TLRs are known to be essential for protective immunity against infection. Murine models have previously suggested that the TLRs 2, 9, and 8 could be involved in the recognition of H pylori by dendritic cells, which traverse epithelial tight junctions in the intestine to sample luminal bacteria. 33, 34 Among these, TLR2 represents the only cell surface receptor/ligand system that can cause a pronounced anti-inflammatory signature. 33 TLR1, on the other hand, is known to represent one of the coreceptors of TLR2. Both proteins can form a heterodimer that recognizes triacylated lipopeptides from the cell envelope of gram-negative bacteria. 35, 36 The fine structure of H pylori lipid A can consist of triacylated lipopeptides, which would make it an ideal ligand for TLR2-TLR1 binding. 37 However, this conclusion remains speculative, because information was not available regarding the identities of the different H pylori strains in the study cohorts. Recent studies showed the association of rs5743618, a nonsynonymous SNP in linkage with rs10004195 identified in this study, with Chlamydia trachomatis infection 38 and leprosy, 39 indicating the involvement of TLR1 in bacterial infection.
Additional studies have shown that the specific H pylori-induced dendritic cell cytokine profile polarizes the balance between mucosal T helper 1 (T H 1) and T helper 17 (T H 17) cells on one side and regulatory T helper (T reg ) cells on the other side, toward a T regbiased response. This would cause suppression of the H pylori-specific T H 1/ T H 17-dependent responses and correlated with a higher degree of H pylori infection. 40, 41 These results demonstrated that H pylori, by inducing a T reg -skewed response via active tolerogenic programming of dendritic cells, limits the host's ability to eradicate the pathogen and can result in persistence of H pylori infection. 41 In light of animal data 33, 34 and new data generated by this study, one hypothesis is that the protective minor allele-associated haplotype might confer less effective antiinflammatory TLR1-TLR2 signaling. The single nonsynonymous SNP rs4833095 in TLR1 identified as associated with H pylori seroprevalence represents a putative candidate for such a predicted modification of TLR1-TLR2 function, because the position of the Asn248Ser amino acid substitution is located within the immediate vicinity of the TLR1 ligand binding and dimerization site. 32 This hypothesis could be tested in a recently generated knockout animal. 42 In the present study, the allele associated with higher anti-H pylori IgG titers was also associated with higher TLR1 expression. Whether the nonsynonymous SNP rs4833095 is associated with H pylori treatment failure or recurrence requires further investigation, because the cross-sectional design of this population-based study does not allow an evaluation of these parameters.
In the GWAS meta-analysis, the 1q23.3 region was also significantly associated with the H pylori phenotype. The minor allele of the top-ranked SNP, rs368433, was associated with low anti-H pylori IgG titers, decreased blood levels of HSPA6 and FCGR2A, and increased expression levels of FCGR2B. The FCGR2B-encoded Fcy receptor IIB also seems plausibly related to seroprevalence, because genetic variations affecting the receptor's affinity for IgG subclass 2 (IgG2) have been reported. 43 Furthermore, it has been observed that neutrophils from individu-als who are homozygous for one of these SNPs can phagocytose IgG2-opsonized bacteria more effectively. 44 On the other hand, the increased expression of FCGR2B on the surface of immune cells might simply result in more pronounced cellular titration of IgGs and, consequently, decreased titers of soluble IgG. Additional studies are required to validate the association and, if validated, to explore the underlying biological mechanisms related to the observed effects.
At this time, the clinical implications of the current findings are unknown. Based on these data, genetic testing to evaluate H pylori susceptibility outside of research projects would be premature. This study has several limitations. First, the study was conducted among participants phenotyped only for seroprevalence and not symptomatic H pylori infection. In agreement with previous studies, this study shows a quantitative correlation for H pylori serology and H pylori fecal antigen; however, the correlation is weak (Spearman = 0.59). Therefore, additional studies are needed to determine if the observed associations are present in populations phenotyped for clinically significant infection. Second, the validity of the current results are restricted to individuals of European ancestry. Additional GWASs of cohorts with non-European ancestry will be required to determine the extent to which the results can be generalized to other ethnic groups.
Third, it is also not clear if the results would be reproducible in a cohort exposed to a significantly higher pathogen pressure. A significant proportion of the study population had no definitive serological evidence of H pylori exposure, nor were study population-specific data available for H pylori exposure rates. It is technically possible that the observed associations are related to effective exposure to H pylori, rather than serologic conversion. Fourth, the FCGR2A/B locus showed genome-wide significant association in the meta-analysis under a fixed-effects model only and requires replication in independent, ethnically diverse, cohorts.
GWAS meta-analysis identified an association between TLR1 and H pylori seroprevalence, a finding that requires replication in other independent populations. If confirmed, genetic variations in TLR1 may help explain some of the observed variation in individual risk for H pylori infection.
